Investigates efficacy and safety of IVIG in autoimmune encephalitis, suggesting potential benefits for refractory cases.
This study aimed to investigate the efficacy and safety of intravenous immunoglobulin (IVIG) in patients with autoimmune encephalitis (AE) refractory to steroid pulse therapy.
No takes yet. Share an insight, caveat, or question.
Sakamoto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Neurology